C07J 41/0033
Not covered by c07j41/0005
Official title: {not covered by C07J41/0005}
C07J41/0033 (Not covered by c07j41/0005) appears on 1,243 US grants and 937 published applications in this corpus.
Search patents in C07J- Granted patents
- 1,243
- Published applications
- 937
- Assignees
- 579
- Inventors
- 2,584
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 21 | 0 |
| 1977 | 21 | 0 |
| 1978 | 23 | 0 |
| 1979 | 18 | 0 |
| 1980 | 23 | 0 |
| 1981 | 21 | 0 |
| 1982 | 15 | 0 |
| 1983 | 12 | 0 |
| 1984 | 22 | 0 |
| 1985 | 17 | 0 |
| 1986 | 22 | 0 |
| 1987 | 18 | 0 |
| 1988 | 12 | 0 |
| 1989 | 18 | 0 |
| 1990 | 32 | 0 |
| 1991 | 21 | 0 |
| 1992 | 26 | 0 |
| 1993 | 28 | 0 |
| 1994 | 24 | 0 |
| 1995 | 33 | 0 |
| 1996 | 38 | 0 |
| 1997 | 51 | 0 |
| 1998 | 48 | 0 |
| 1999 | 39 | 0 |
| 2000 | 32 | 0 |
| 2001 | 26 | 6 |
| 2002 | 33 | 35 |
| 2003 | 19 | 34 |
| 2004 | 22 | 26 |
| 2005 | 13 | 29 |
| 2006 | 17 | 14 |
| 2007 | 12 | 15 |
| 2008 | 8 | 14 |
| 2009 | 14 | 24 |
| 2010 | 16 | 27 |
| 2011 | 5 | 21 |
| 2012 | 12 | 35 |
| 2013 | 15 | 32 |
| 2014 | 16 | 40 |
| 2015 | 27 | 46 |
| 2016 | 24 | 63 |
| 2017 | 42 | 57 |
| 2018 | 32 | 44 |
| 2019 | 53 | 54 |
| 2020 | 44 | 54 |
| 2021 | 36 | 56 |
| 2022 | 30 | 51 |
| 2023 | 29 | 50 |
| 2024 | 24 | 41 |
| 2025 | 29 | 38 |
| 2026 | 10 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07J 41/0055The 17-beta position being substituted by an uninterrupted chain of at least510
- C07J 41/0094Containing nitrile radicals, including thiocyanide radicals254
- C07J 41/005The 17-beta position being substituted by an uninterrupted chain of only two236
- C07J 41/0077Substituted in position 11-beta by a carbon atom, further substituted by a149
- C07J 41/0072The a ring of the steroid being aromatic144
- C07J 41/0088Containing unsubstituted amino radicals144
- C07J 41/0038With an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and103
- C07J 41/0066The 17-beta position being substituted by a carbon atom forming part of63
Recent patents
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof6 Oct 2026US 12,753,204 B2Enanta Pharmaceuticals, Inc.
- Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer29 Sep 2026US 12,747,263 B2Evestra, Inc.
- Crystal form of 3-hydroxy-5-pregnane-20-one derivative, and preparation method therefor and use thereof15 Sep 2026US 12,735,448 B2TWi Biotechnology, Inc.
- Bile acid-GCPII inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (IBD)4 Aug 2026US 12,698,306 B2Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- Neuroactive steroids and their methods of use7 Jul 2026US 12,673,970 B2Sage Therapeutics, Inc.
- Spleen-targeted lipid nanoparticles1 Oct 2026US 2026/0294826 A1Beijing Jitai Pharmaceutical Technology Co., Ltd.
- Neurosteroids and Prodrugs Thereof24 Sep 2026US 2026/0285897 A1Emory University
- Salt form and polycrystalline form of allopregnanolone derivative, preparation method therefor, and use thereof17 Sep 2026US 2026/0274887 A1Nanjing Minova Pharmaceutical Co., Ltd.
- Estradiol prodrugs and methods of use thereof27 Aug 2026US 2026/0248809 A1The United States Government as represented by the Department of Veterans Affairs
- Antipseudomonal fusidic acid compounds20 Aug 2026US 2026/0240869 A1The Board of Trustees of the University of Illinois
Most cited
By later US patents
- Method for delivering nucleic acids into cells278US 5,283,185 AMcMaster University · 1994
- Oligonucleotide having enhanced binding affinity276US 5,486,603 AGilead Sciences, Inc. · 1996
- Conjugates and compositions for cellular delivery194US 7,491,805 B2Sirna Therapeutics, Inc. · 2009
- 4-Aza-17.beta.-substituted-5.alpha.-androstan-3-one-reductase inhibitors159US 4,377,584 AMerck & Co., Inc. · 1983
- Cationic amphiphile/DNA complexes149US 5,948,767 AGenzyme Corporation · 1999